|
Market Closed -
Euronext Paris
03:55:00 07/11/26 am AEDT
|
5-day change | 1st Jan Change | ||
| 0.2850 EUR | +0.88% |
|
-4.68% | -4.36% |
| 30/10 | Nicox sharply narrows first-half 2026 loss and secures cash runway through 2028 |  |
| 30/10 | Nicox S.A. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| Market Cap | 25.12M 28M 22.96M 20.95M 39.48M 2.63B 40.72M 277M 110M 1.4B 105M 103M 4.43B | P/E 2026 * |
-5.7x | P/E 2027 * | 14.3x |
|---|---|---|---|---|---|
| Enterprise Value | 25.12M 28M 22.96M 20.95M 39.48M 2.63B 40.72M 277M 110M 1.4B 105M 103M 4.43B | EV / Sales 2026 * |
8.37x | EV / Sales 2027 * | 2.51x |
| Free-Float |
96.11% | Yield 2026 * |
-
| Yield 2027 * | - |
Euronext ParisEUR
| Markets | Quality | ||
|---|---|---|---|
Euronext Paris
| ALCOX | Real-time | |
Boerse Muenchen
| NXOA | Real-time | |
|
CBOE
| COXp | Real-time | |
|
Deutsche Boerse AG
| NXOA | Delayed | |
|
CBOE
| 0RCQ | Real-time | |
|
Börse Stuttgart
| NXOA | Delayed |
| 1 day | +0.88% | ||
| 1 week | -4.68% | ||
| Current month | -4.68% | ||
| 1 month | -10.38% | ||
| 3 months | -25.29% | ||
| 6 months | -26.92% | ||
| Current year | -4.36% |
| 1 week | 0.28 |  | 0.32 |
| 1 month | 0.28 | | 0.32 |
| Current year | 0.28 | | 0.57 |
| 1 year | 0.28 | | 0.57 |
| 3 years | 0.14 | | 0.65 |
| 5 years | 0.14 | | 3.24 |
| 10 years | 0.14 | | 13.68 |
| Manager | Title | Age | Since |
|---|---|---|---|
Gavin Spencer
CEO | Chief Executive Officer | 55 | 28/02/2024 |
Sandrine Gestin
DFI | Director of Finance/CFO | 58 | 01/01/2015 |
Emmet Purtill
PRN | Corporate Officer/Principal | - | 01/01/2006 |
| Director | Title | Age | Since |
|---|---|---|---|
Gavin Spencer
BRD | Director/Board Member | 55 | 08/04/2024 |
Damian Marron
CHM | Chairman | 64 | 16/07/2024 |
Marc Bozec
BRD | Director/Board Member | - | 16/07/2024 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 29/1/22 | Free | Chief Executive Officer | 15,000 | 0.0348% | ||
| 16/2/21 | Exercice | Chief Executive Officer | 10,000 | 0.0270% | ||
| 1/2/20 | Free | Chief Executive Officer | 10,000 | 0.0300% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.88% | -4.68% | -12.17% | -38.11% | 28M | |
| -0.79% | -4.48% | +44.44% | +127.49% | 1,206B | |
| +1.43% | +1.11% | +47.73% | +82.08% | 665B | |
| +1.07% | -1.21% | +32.99% | +106.31% | 515B | |
| -0.36% | -3.25% | +47.17% | +64.58% | 381B | |
| -0.14% | -1.87% | +71.05% | +40.63% | 362B | |
| -0.78% | -0.52% | +30.57% | +57.98% | 307B | |
| -0.80% | -0.21% | +8.54% | +35.56% | 289B | |
| +0.03% | -1.20% | +45.89% | +68.76% | 249B | |
| -0.41% | -2.22% | +35.24% | +105.68% | 207B | |
| Average | +0.01% | -1.85% | +35.15% | +65.10% | 417.98B | |
| Weighted average by Cap. | -0.04% | -1.96% | +42.24% | +88.38% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3M 3.34M 2.74M 2.5M 4.72M 314M 4.86M 33.05M 13.18M 168M 12.55M 12.29M 530M | 10M 11.15M 9.14M 8.34M 15.72M 1.05B 16.21M 110M 43.93M 559M 41.85M 40.95M 1.77B |
| Net income | -5M -5.57M -4.57M -4.17M -7.86M -524M -8.11M -55.08M -21.96M -280M -20.92M -20.48M -883M | 2M 2.23M 1.83M 1.67M 3.14M 210M 3.24M 22.03M 8.79M 112M 8.37M 8.19M 353M |
| Net Debt | - | - |
Employees
10
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 06/11/26 | EUR 0.2850 | +0.88% | 128,245 |
| 05/11/26 | EUR 0.2825 | +0.36% | 88,398 |
| 04/11/26 | EUR 0.2815 | +0.18% | 68,479 |
| 03/11/26 | EUR 0.2810 | -3.10% | 185,815 |
| 02/11/26 | EUR 0.2900 | -3.01% | 136,318 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.2850EUR
Average target price
1.000EUR
Spread / Average Target
+250.88%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ALCOX Stock
Select your edition
All financial news and data tailored to specific country editions
